Efficient testing using surrogate information
From MaRDI portal
Cites work
- A general framework to assess complex heterogeneity in the strength of a surrogate marker
- A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
- Generalized Cross-Validation as a Method for Choosing a Good Ridge Parameter
- scientific article; zbMATH DE number 837911 (Why is no real title available?)
- scientific article; zbMATH DE number 3222478 (Why is no real title available?)
- Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm
- Inference using surrogate outcome data and a validation sample
- Power of testing for exposure effects under incomplete mediation
- Predictive probability of success using surrogate endpoints
- Principal stratification in causal inference
- Robust estimation of the proportion of treatment effect explained by surrogate marker information
- Semi-Supervised Triply Robust Inductive Transfer Learning
- Statistical Methods for Clinical Studies in the Presence of Surrogate End Points
- Surrogacy validation for time-to-event outcomes with illness-death frailty models
- Surrogate marker evaluation: a tutorial using R
- Testing for Heterogeneity in the Utility of a Surrogate Marker
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- Using a surrogate marker for early testing of a treatment effect
- Using a surrogate with heterogeneous utility to test for a treatment effect
Cited in
(1)
This page was built for publication: Efficient testing using surrogate information
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6905073)
